Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.

scientific article published in January 2008

Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/RHEUMATOLOGY/KEM311
P698PubMed publication ID18077493
P5875ResearchGate publication ID5772066

P50authorGeorge D. KitasQ37831495
Antonios Stavropoulos-KalinoglouQ54268921
Moses ElisafQ56966508
P2093author name stringP Nightingale
K M J Douglas
G S Metsios
V F Panoulas
M D Kita
P433issue1
P921main subjectrheumatoid arthritisQ187255
hypertensionQ95566669
P304page(s)72-75
P577publication date2008-01-01
P1433published inRheumatologyQ7320492
P1476titleLong-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis
P478volume47

Reverse relations

cites work (P2860)
Q48049092A Novel Model of Dexamethasone-Induced Hypertension: Use in Investigating the Role of Tyrosine Hydroxylase.
Q50076043A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States
Q38525320Analysis of patents on anti-rheumatoid arthritis therapies issued in China
Q37808969Anti-inflammatory glucocorticoid drugs: reflections after 60 years
Q51673816Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis?
Q44733067Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
Q59303860Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white c
Q37436281Assessment of left atrial mechanical functions and atrial electromechanical delay in Juvenile idiopathic arthritis by tissue Doppler echocardiography
Q58621582Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and O
Q92380899Blood pressure and body fat percent in women with NMOSD
Q92464675Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment
Q33943374Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment
Q34495257Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america
Q34081242Cardiovascular involvement in autoimmune diseases
Q38090373Cardiovascular risk in juvenile idiopathic arthritis
Q37098605Cognitive impairment in persons with rheumatoid arthritis
Q36758324Comorbidity profile among patients with rheumatoid arthritis and the impact on prescriptions trend
Q92187601Dexamethasone Causes Hypertension in Rats Even Under Chemical Blockade of Peripheral Sympathetic Nerves
Q37804548Drug Monitoring in Systemic Lupus Erythematosus: A Systematic Review
Q37774304Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality
Q36013882Factors associated with parasympathetic activation following exercise in patients with rheumatoid arthritis: a cross-sectional study
Q39991479Galectin-2 (LGALS2) 3279C/T polymorphism may be independently associated with diastolic blood pressure in patients with rheumatoid arthritis
Q38388487Glucocorticoid safety for treating rheumatoid arthritis
Q57062369Glucocorticoid treatment in juvenile idiopathic arthritis
Q37052792Glucocorticoids: complications to anticipate and prevent
Q37558668Hypertension after pediatric cardiac transplantation: detection, etiology, implications and management
Q37158219Hypertension in rheumatoid arthritis.
Q58160099Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study
Q37420081Incidence and risk factors for early-onset hypertension after allogeneic hematopoietic stem cell transplantation in children
Q36254129Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study
Q43251970Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study
Q37281848Inflammation and hypertension in rheumatoid arthritis
Q39002555Inhibition of proteasome-mediated glucocorticoid receptor degradation restores nitric oxide bioavailability in myocardial endothelial cells in vitro.
Q84958818Is the prevalence of arterial hypertension in rheumatoid arthritis and osteoarthritis associated with disease?
Q33596583Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis
Q44438694Lack of an association of GNB3 C825T polymorphism and blood pressure in patients with rheumatoid arthritis
Q37129611Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study.
Q38026796Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies
Q37428743Management of cardiovascular disease risk in chronic inflammatory disorders
Q37058791Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion
Q37975943Managing cardiovascular risk in patients with chronic inflammatory diseases.
Q39882466Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.
Q92841540Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: A nationwide register study
Q38098935Novel risk factors for cardiovascular disease in rheumatoid arthritis
Q35236926Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis
Q37328983Perceived and actual risk of cardiovascular disease in patients with rheumatoid arthritis in Korea: A cross-sectional study
Q37730557Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.
Q37549027Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair?
Q53502883Prevention of stroke in rheumatoid arthritis.
Q82076745Rheumatoid arthritis and cardiovascular disease
Q36812587Rheumatoid arthritis and cardiovascular disease: an update on treatment issues
Q39361426Role of Inflammatory Diseases in Hypertension
Q92645330Role of lentivirus-mediated overexpression of SOCS3 in proliferation and apoptosis of fibroblasts-like synoviocytes in Lewis rats with adjuvant-induced rheumatoid arthritis
Q52628833Safety and efficacy of alternate-day corticosteroid treatment as adjunctive therapy for rheumatoid arthritis: a comparative study.
Q47110507Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
Q38247488Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.
Q37689488Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins
Q92377672The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Q64111046The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis
Q35135831The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Q28577820The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1α expression
Q37137840The relationship between cognitive function and physical function in rheumatoid arthritis

Search more.